[Clinical evaluation of the effectiveness and tolerance of Sulfanizolon 0.25% eye suspension Polfa].
D000328:Adult; D002648:Child; D003231:Conjunctivitis / Q000188:drug therapy*; D004338:Drug Combinations; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007500:Iritis / Q000188:drug therapy*; D008297:Male; D009883:Ophthalmic Solutions; D011239:Prednisolone / Q000627:therapeutic use*; D013409:Sulfacetamide / Q000627:therapeutic use*
D004338:Drug Combinations; D009883:Ophthalmic Solutions; D013409:Sulfacetamide; D011239:Prednisolone
Wyniki badań klinicznych skuteczności i tolerancji perparatu Sulfanizolon 0,25%-zawiesina oczna "Polfa"